Susquehanna International Group
VTVT icon

Susquehanna International Group’s vTv Therapeutics VTVT Stock Holding History

Susquehanna International Group’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-507
Closed -$9.69K – 13394
2023
Q3 		$9.69K Sell
507
-1,399
-73% -$34.2K ﹤0.01% 11721
2023
Q2 		$56.4K Buy
1,906
+1,524
+399% +$48.4K ﹤0.01% 11286
2023
Q1 		$12.3K Buy
+382
New +$13K ﹤0.01% 12164
2022
Q4 		– Sell
-556
Closed -$22K – 13798
2022
Q3 		$22K Buy
556
+39
+8% +$1.53K ﹤0.01% 12575
2022
Q2 		$16K Sell
517
-61
-11% -$1.56K ﹤0.01% 12417
2022
Q1 		$17K Buy
+578
New +$17.3K ﹤0.01% 12671
2021
Q3 		– Sell
-1,069
Closed -$97K – 13663
2021
Q2 		$97K Buy
+1,069
New +$108K ﹤0.01% 12112
2020
Q2 		– Sell
-407
Closed -$31K – 11012
2020
Q1 		$31K Buy
+407
New +$39.1K ﹤0.01% 9824
2017
Q1 		– Sell
-307
Closed -$59K – 10068
2016
Q4 		$59K Buy
+307
New +$70.6K ﹤0.01% 9250
2015
Q4 		– Sell
-548
Closed -$143K – 10047
2015
Q3 		$143K Buy
+548
New +$191K ﹤0.01% 8958

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's VTVT Position: Q4 2023 in Review

Susquehanna International Group sold out of vTv Therapeutics (VTVT) in Q4 2023, closing a stake of 507 shares — an estimated $9.69K sold.

Susquehanna International Group first reported a position in VTVT in Q3 2015 and held it in 10 quarters. The position peaked at $143K in Q3 2015. 14 funds tracked by Wall St. Rank hold VTVT as of Q4 2023.

  • Susquehanna International Group reported no remaining vTv Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Susquehanna International Group sold 507 vTv Therapeutics shares in Q4 2023, an estimated $9.69K.
  • Susquehanna International Group first reported a position in vTv Therapeutics in Q3 2015 and held it in 10 quarters.
  • Susquehanna International Group's vTv Therapeutics position peaked at $143K in Q3 2015.
  • 14 funds tracked by Wall St. Rank held vTv Therapeutics as of Q4 2023.

Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.